Endoprosthetic replacement of the proximal tibia for giant cell tumor of bone:a multicenter retrospective study

Ming XU,Kai ZHENG,Xiu-chun YU,Li-ming ZHAO,Yong-cheng HU,Zhen WANG,Zhao-ming YE,Nong LIN,Su-jia WU,Guo-chuan ZHANG,Shi-bing GUO
DOI: https://doi.org/10.3969/j.issn.2095-252X.2017.02.003
2017-01-01
Abstract:Objective To investigate the clinical outcomes of endoprosthetic replacement of giant cell tumors in the proximal tibia. Methods A total of 76 patients with giant cell tumors of bone in the proximal tibia, who had undergone endoprosthetic replacement treatment from June 2000 to February 2014, were enrolled in this study. There were 32 males and 44 females, with an average age of ( 38 ± 6.8 ) years. According to the radiology Campanacci’s classification, 36 cases were classified at primary level III and 13 cases at primary level II. In 27 recurrent patients, 22 cases were classified at level III and 5 cases at level II. According to the tumor range, all tumors underwent extensive resection. Rotating hinge type artificial knee prosthesis was used. The gastrocnemius muscle flap was rotated forward and upward to cover the surface of the tibial prosthesis, and the beginning point of the medial head of the gastrocnemius and the residual proximal patellar tendon were sutured to reconstruct the extensor mechanism. Results A total of 76 patients were followed up, with a median follow-up of 88 months. As for the complications, local recurrence developed in 5 patients, superficial wound unhealing in 8 patients, delayed deep infection in 11 patients, and aseptic loosening in 3 patients. The 5-year survival rate of the prosthesis was 84%, and the 10-year survival rate was 70%. The MSTS score was 24.2 in average. Conclusions For patients with pathological fracture or Campanacci grade III, it is an effective method to treat giant cell tumors in the proximal tibia with the en bloc resection of tumor and rotating hinge type artificial knee prosthesis replacement, which can help restore the knee joint function and improve the patients’ quality of life.
What problem does this paper attempt to address?